Literature DB >> 23083016

Sulfonyl fluoride inhibitors of fatty acid amide hydrolase.

Shakiru O Alapafuja1, Spyros P Nikas, Indu T Bharathan, Vidyanand G Shukla, Mahmoud L Nasr, Anna L Bowman, Nikolai Zvonok, Jing Li, Xiaomeng Shi, John R Engen, Alexandros Makriyannis.   

Abstract

Sulfonyl fluorides are known to inhibit esterases. Early work from our laboratory has identified hexadecyl sulfonylfluoride (AM374) as a potent in vitro and in vivo inhibitor of fatty acid amide hydrolase (FAAH). We now report on later generation sulfonyl fluoride analogs that exhibit potent and selective inhibition of FAAH. Using recombinant rat and human FAAH, we show that 5-(4-hydroxyphenyl)pentanesulfonyl fluoride (AM3506) has similar inhibitory activity for both the rat and the human enzyme, while rapid dilution assays and mass spectrometry analysis suggest that the compound is a covalent modifier for FAAH and inhibits its action in an irreversible manner. Our SAR results are highlighted by molecular docking of key analogs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23083016      PMCID: PMC3678964          DOI: 10.1021/jm301205j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  60 in total

1.  SULFONYL FLUORIDES AS INHIBITORS OF ESTERASES. II. FORMATION AND REACTIONS OF PHENYLMETHANESULFONYL ALPHA-CHYMOTRYPSIN.

Authors:  A M GOLD; D FAHRNEY
Journal:  Biochemistry       Date:  1964-06       Impact factor: 3.162

2.  Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates.

Authors:  Giulio G Muccioli; Nicola Fazio; Gerhard K E Scriba; Wolfgang Poppitz; Fabio Cannata; Jacques H Poupaert; Johan Wouters; Didier M Lambert
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

3.  beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase.

Authors:  Marion Feledziak; Catherine Michaux; Allan Urbach; Geoffray Labar; Giulio G Muccioli; Didier M Lambert; Jacqueline Marchand-Brynaert
Journal:  J Med Chem       Date:  2009-11-26       Impact factor: 7.446

4.  Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor.

Authors:  Douglas S Johnson; Cory Stiff; Scott E Lazerwith; Suzanne R Kesten; Lorraine K Fay; Mark Morris; David Beidler; Marya B Liimatta; Sarah E Smith; David T Dudley; Nalini Sadagopan; Shobha N Bhattachar; Stephen J Kesten; Tyzoon K Nomanbhoy; Benjamin F Cravatt; Kay Ahn
Journal:  ACS Med Chem Lett       Date:  2011-02-10       Impact factor: 4.345

5.  Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity.

Authors:  David A Karanian; Queenie B Brown; Alexandros Makriyannis; Therese A Kosten; Ben A Bahr
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

6.  Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.

Authors:  Marco Mor; Silvia Rivara; Alessio Lodola; Pier Vincenzo Plazzi; Giorgio Tarzia; Andrea Duranti; Andrea Tontini; Giovanni Piersanti; Satish Kathuria; Daniele Piomelli
Journal:  J Med Chem       Date:  2004-10-07       Impact factor: 7.446

7.  X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

Authors:  Mauro Mileni; Joie Garfunkle; Cyrine Ezzili; F Scott Kimball; Benjamin F Cravatt; Raymond C Stevens; Dale L Boger
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

8.  Crucial structural factors and mode of action of polyene amides as inhibitors for mitochondrial NADH-ubiquinone oxidoreductase (complex I).

Authors:  Takehiko Yoshida; Masatoshi Murai; Masato Abe; Naoya Ichimaru; Toshiyuki Harada; Takaaki Nishioka; Hideto Miyoshi
Journal:  Biochemistry       Date:  2007-08-09       Impact factor: 3.162

9.  Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

Authors:  F Scott Kimball; F Anthony Romero; Cyrine Ezzili; Joie Garfunkle; Thomas J Rayl; Dustin G Hochstatter; Inkyu Hwang; Dale L Boger
Journal:  J Med Chem       Date:  2008-02-05       Impact factor: 7.446

10.  Chemical characterization of a family of brain lipids that induce sleep.

Authors:  B F Cravatt; O Prospero-Garcia; G Siuzdak; N B Gilula; S J Henriksen; D L Boger; R A Lerner
Journal:  Science       Date:  1995-06-09       Impact factor: 47.728

View more
  12 in total

1.  2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.

Authors:  Alexandros Makriyannis
Journal:  J Med Chem       Date:  2014-05-01       Impact factor: 7.446

2.  Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors.

Authors:  Michael Z Leonard; Shakiru O Alapafuja; Lipin Ji; Vidyanand G Shukla; Yingpeng Liu; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman; Brian D Kangas
Journal:  J Pharmacol Exp Ther       Date:  2017-09-25       Impact factor: 4.030

3.  Novel tail and head group prostamide probes.

Authors:  David F Finnegan; Erin L Shelnut; Spyros P Nikas; Nan Chiang; Charles N Serhan; Alexandros Makriyannis
Journal:  Bioorg Med Chem Lett       Date:  2015-02-04       Impact factor: 2.823

Review 4.  On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence.

Authors:  Karen Jaqueline Paredes-Ruiz; Karla Chavira-Ramos; Mario Orozco-Morales; Cimen Karasu; Alexey A Tinkov; Michael Aschner; Abel Santamaría; Ana Laura Colín-González
Journal:  Neurotox Res       Date:  2021-11-06       Impact factor: 3.911

5.  A regio- and stereoselective Heck-Matsuda process for construction of γ-aryl allylsulfonyl fluorides.

Authors:  Hao-Yong Qin; Houying Gui; Zai-Wei Zhang; Tao Shu; Hua-Li Qin
Journal:  RSC Adv       Date:  2022-07-04       Impact factor: 4.036

6.  Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.

Authors:  Charles W Schindler; Maria Scherma; Godfrey H Redhi; Subramanian K Vadivel; Alexandros Makriyannis; Steven R Goldberg; Zuzana Justinova
Journal:  Psychopharmacology (Berl)       Date:  2016-01-23       Impact factor: 4.530

7.  Small molecule inhibitors of anthrax edema factor.

Authors:  Guan-Sheng Jiao; Seongjin Kim; Mahtab Moayeri; April Thai; Lynne Cregar-Hernandez; Linda McKasson; Sean O'Malley; Stephen H Leppla; Alan T Johnson
Journal:  Bioorg Med Chem Lett       Date:  2017-11-24       Impact factor: 2.823

8.  A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models.

Authors:  Linda A Parker; Cheryl L Limebeer; Erin M Rock; Martin A Sticht; Jordan Ward; Greig Turvey; Othman Benchama; Girija Rajarshi; JodiAnne T Wood; Shakiru O Alapafuja; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2016-04-06       Impact factor: 4.530

9.  The Impact of the hAPP695SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways.

Authors:  Mona Khorani; Gerd Bobe; Donald G Matthews; Armando Alcazar Magana; Maya Caruso; Nora E Gray; Joseph F Quinn; Jan F Stevens; Amala Soumyanath; Claudia S Maier
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 10.  Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants.

Authors:  Shintaro Ogawa; Hiroshi Kunugi
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.